FDA upgrades egg recall to highest risk level as salmonella sickens dozens across several states

The FDA has reclassified the current egg recall to Class I, a designation reserved for situations where there is a reasonable probability that the use of a product will cause serious adverse health consequences or death. This shift follows an ongoing salmonella outbreak affecting consumers across several states, specifically throughout the American south and south-west. Consequently, 19 million eggs have been pulled from distribution channels to mitigate further exposure to the pathogen.

Coverage from The Independent and DW confirms the scale of the recall at 19 million units, while The Guardian notes the geographic concentration in the southern and south-western regions of the United States. Media reports emphasize the urgency of checking individual cartons, as the reclassification highlights the potential for severe health outcomes associated with the consumption of the affected batches. While the recall status is clear, coverage does not yet specify the precise distribution brands or specific manufacturing facilities responsible for the contamination.

Additionally, details regarding the exact number of reported illnesses or the specific duration for which these products remained on store shelves remain thin. Observers are tracking further FDA instructions regarding which specific lot codes consumers should prioritize for disposal or return.